The spin-off company from Vall d’Hebron Institute of Research (VHIR) D-Sight, both members of CATALONIA.HEALTH, has been awarded with the Disruptive Innovation Award at the 18th edition of the EmprendeXXI Awards. 

The biopharmaceutical company AbilityPharma, a member of CATALONIA.HEALTH, announced that the data of its Phase I/IIa ENDOLUNG trial evaluating Ibrilatazar (ABTL0812) in combination with chemotherapy (paclitaxel/carboplatin) for patients with stage III/IV squamous non-small cell lung cancer (sq-NSCLC) has been published in the Lung Cancer journal.

The project aims to improve children's medical care at home by analysing indoor pollutants and producing personalised digital recommendations for families and health professionals. AYRA is coordinated by a consortium of the same name made up of the Hospital Sant Joan de Déu Barcelona, CATALONIA.HEALTH, the BCD Foundation, Domestic Data Streamers, PUMBA and TheLeftBit, leading organisations in health, design, technology and data visualisation.

The clinical-stage biotechnology company OneChain Immunotherapeutics, a member of CATALONIA.HEALTH, has announced the appointment of Barbara Krebs-Pohl as the new Chair of the Board of Directors. 

Aortyx, the Barcelona-based medtech scaleup and CATALONIA.HEALTH members, has raised 13.8M EUR Series A funding round led by Ship2B Ventures. The funding will be used to reach the milestone of first-in-human readiness, bringing their product – a bioresorbable patch that treats aortic tears – closer to market.

SpliceBio has announced the closing of a $135 million Series B financing round. The round, the largest in the biotech sector in Spain, is co-led by new investors EQT Life Sciences and Sanofi Ventures, with the participation of Roche Venture Fund, and all existing investors.

Despite a global context in which investment has decreased in 2024, the data from Catalonia reflect a positive trend, as anticipated in last year's study, which predicted a global increase that would be transferred to the local market months later. For its part, according to the Bioregió study, medtech with 131 million euros is the subsector with the most significant increase in 2024, almost tripling the level of 2023. In the same line of growth is biotechnology, with 29 million euros. 

L’estudi sobre la inversió al sector de la salut a Catalunya 2024, elaborat per CATALONIA.HEALTH i EY, destaca que el 57% de les empreses del sector ha assolit el seu equilibri financer. En el cas de les startups, el 17% ha aconseguit llançar al mercat productes o serveis comercials.

The biotech company Nuage Therapeutics, a member of CATALONIA.HEALTH, has received a capital injection of €1.8 million. 

The Vall de Hebron Research Institute (VHIR), a member of CATALONIA.HEALTH, has obtained ISO 56001:2024 certification, which certifies excellence in innovation management.

The 3DBBT consortium, led by the MAV Cluster and formed by this entity and CATALONIA. HEALTH, the companies DAN*NA and Perdigó, and the foundations Elisava and CIM-UPC, is finalising the design of synthetic bone tissue through 3D printing, which will facilitate the development of new bone models with a high level of bio-realism and will allow real access to personalised medicine.

The consultancy GENESIS Biomed, a member of CATALONIA.HEALTH, held its 2025 Annual Symposium at the Auditori Antoni Caparrós of the Barcelona Science Park, which brought together more than 110 professionals from the local and national ecosystem, from public entities and private companies.

The venture capital company Ysios Capital, a member of CATALONIA.HEALTH, has announced that its investee company, ReproNovo has closed a $65 milions Series A financing round.

The pharmaceutical company Reig Jofre, a member of CATALONIA.HEALTH, has been selected to receive a €13 million grant from the Centre for the Development of Industrial Technology (CDTI). 

The neurotechnology company INBRAIN Neuroelectronics, a member of CATALONIA.HEALTH, has received a 4 million euros’ grant from the Spanish Ministry of Industry and Tourism through the PERTE Chip initiative, a national programme to support the most revolutionary innovation in microelectronics, semiconductors and deeptech.

The public-private consortium formed by the biopharmaceutical company Oniria Therapeutics, a member of CATALONIA.HEALTH, the Spanish National Research Council (CSIC) and the Vall d'Hebron Institute of Oncology (VHIO) has obtained 2 million euros of funding from the Ministry of Science, Innovation and Universities of Spain and the European Union, through the Public-Private Collaboration Program 2023. 

CATALONIA.HEALTH incorpora a Arantxa Sanz com a directora general de l’entitat. Amb aquest nou lideratge, s’inicia una nova etapa enfocada a consolidar el seu posicionament dins l’ecosistema i a reforçar les aliances entre el món científic, empresarial i institucional.

The medical diagnostics company Deepull, a member of CATALONIA.HEALTH, has announced the closing of a €50 million Series C financing round. 

New studies emphasize how peptide-based launches, the core of the Gate2Brain technological platform, a member of CATALONIA.HEALTH, are poised to revolutionise drug administration through the blood-brain barrier. 

Why are biotechs booming in Barcelona? Nature, the most prestigious scientific journal in the world, has highlighted three biotech startups based in Barcelona and members of CATALONIA.HEALTH, Nuage Therapeutics, Ona Therapeutics and SpliceBio.